<?xml version="1.0"?>
<Articles JournalTitle="Iranian Journal of Public Health">
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Iranian Journal of Public Health</JournalTitle>
      <Issn>2251-6085</Issn>
      <Volume>47</Volume>
      <Issue>7</Issue>
      <PubDate PubStatus="epublish">
        <Year>2018</Year>
        <Month>07</Month>
        <Day>16</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Haplotype Analysis of Peroxisome Proliferator-activated Receptor &#x3B3; Gene Polymorphisms and the Lipoprotein (a) Level</title>
    <FirstPage>973</FirstPage>
    <LastPage>979</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Chao</FirstName>
        <LastName>SHEN</LastName>
        <affiliation locale="en_US">Dept. of Epidemiology, School of Public Health, Medical College of Soochow University, Suzhou, China	AND The Center for Disease Control and Prevention of Suzhou Industry Park, SuZhou, China</affiliation>
      </Author>
      <Author>
        <FirstName>Wei</FirstName>
        <LastName>FAN</LastName>
        <affiliation locale="en_US">Dept. of Epidemiology, School of Public Health, Medical College of Soochow University, Suzhou, China</affiliation>
      </Author>
      <Author>
        <FirstName>Hui-Jian</FirstName>
        <LastName>XIE</LastName>
        <affiliation locale="en_US">Dept. of Epidemiology, School of Public Health, Medical College of Soochow University, Suzhou, China</affiliation>
      </Author>
      <Author>
        <FirstName>Ming</FirstName>
        <LastName>WU</LastName>
        <affiliation locale="en_US">Center for Disease Control, Nanjing, Jiangsu Province, China</affiliation>
      </Author>
      <Author>
        <FirstName>Zheng-Yuan</FirstName>
        <LastName>ZHOU</LastName>
        <affiliation locale="en_US">Center for Disease Control of Changshu, Suzhou, China</affiliation>
      </Author>
      <Author>
        <FirstName>Zhi-Rong</FirstName>
        <LastName>GUO</LastName>
        <affiliation locale="en_US">Dept. of Epidemiology, School of Public Health, Medical College of Soochow University, Suzhou, China</affiliation>
      </Author>
      <Author>
        <FirstName>Chen</FirstName>
        <LastName>DONG</LastName>
        <affiliation locale="en_US">Dept. of Epidemiology, School of Public Health, Medical College of Soochow University, Suzhou, China</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2018</Year>
        <Month>07</Month>
        <Day>16</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2018</Year>
        <Month>07</Month>
        <Day>16</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">&#xA0;
&#xD;

Background: Lipoprotein (a) [Lp(a)], as an independent risk factor for cardiovascular disease, is more likely to be genetically determined according to the increasing evidence of epidemiologic and clinical studies in recent years. Peroxisome proliferator-activated receptor (PPAR)&#x3B3;, the ligand-activated transcription factors, was considered as an indispensable role in the process of lipid metabolism. This study was designed to explore the associations of three single-nucleotide polymorphisms (SNPs) and the haplotypes of the peroxisome proliferator-activated receptor (PPAR)&#x3B3; gene with the level of Lp(a).
&#xD;

Methods: Participants were recruited under the framework of the PMMJS (The Prevention of Metabolic Syndrome (MS) and Multi-metabolic Disorders in Jiangsu Province of China Study) from Apr 1999 to Jun 2004. Overall, 644 subjects were randomly selected and 3 SNPs of PPAR&#x3B3; gene (rs10865710, rs1805192, rs4684847) were genotyped.
&#xD;

Results: After adjusting for age, sex, cigarette smoking, alcohol drinking, waist circumference and body mass index, rs4684847 was significantly associated with Lp (a). The presence of the rs4684847 T allele (CT+TT) have a lower level of Lp (a) than the allele (CC) in the dominant model, mean difference was -27.30 (95%CI:-52.88~-1.73) mg/L, P&lt;0.05. G-P-T and G-A-T haplotype were associated with lower levels of Lp (a) (P=0.0041 and&lt;0.0001), mean difference was 49.79(95%CI:-97.52~-2.06) mg/L and 17.75(95%CI:-25.75~-9.75) mg/L.
&#xD;

Conclusion: PPAR gamma polymorphisms (rs10865710, rs1805192, rs4684847) and haplotypes may be the genetic risk factors for Lp (a) level.
&#xD;

&#xA0;
&#xD;

&#xA0;</abstract>
    <web_url>https://ijph.tums.ac.ir/index.php/ijph/article/view/14041</web_url>
    <pdf_url>https://ijph.tums.ac.ir/index.php/ijph/article/download/14041/6038</pdf_url>
  </Article>
</Articles>
